Paul Tudor Jones G1 Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $163,063 - $517,743	-63,449 Reduced 56.28%	49,297 $132,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $148,574 - $386,464	28,627 Added 34.03%	112,746 $612,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $202,431 - $665,243	39,155 Added 87.08%	84,119 $1.05 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $181,654 - $382,643	44,964 New	44,964 $222,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $573,231 - $1.06 Million	-32,607 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $64,566 - $119,849	5,875 Added 21.98%	32,607 $587,000
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $308,754 - $634,885	26,732 New	26,732 $309,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $86,297 - $268,301	-5,227 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $225,545 - $355,279	5,227 New	5,227 $273,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.